I expected that becoming cancer-free would mean getting my old life back. Nothing could be further from the truth.

A recent trial reveals metformin does not enhance survival in metastatic prostate cancer but offers significant metabolic ...

With regard to the choice of bone-protecting agent, denosumab (Xgeva) improved bone density and reduced fracture risk in a ...

Berlin: Bayer has received marketing authorization from the European Commission in the European Union (EU) for Nubeqa ...

European Union approves Bayer’s Nubeq for patients with advanced prostate cancer: Berlin Tuesday, July 22, 2025, 11:00 Hrs [IST] The European Commission has granted marketing au ...

In patients with biochemical recurrence after prostate cancer surgery, the optimal duration of hormone therapy after salvage radiation therapy has been debated.

Androgen deprivation therapy (ADT) has long been a foundation in the management of prostate cancer. Since the introduction of ...

During a live event, Jahan Aghalar, MD, discussed the efficacy and safety of darolutamide plus ADT in mHSPC in the ARANOTE ...

Investigators compared early oncologic outcomes by staging modality among men diagnosed with very high-risk prostate cancer.

With an estimated 1.5 million new cases and 397,000 deaths worldwide, prostate cancer is the world's second most frequent ...

When standard cancer treatments begin to fail, especially in aggressive or advanced stages, oncologists are increasingly ...

I Orion’s collaboration partner Bayer announced today that the European Commission has granted marketing authorization in the European Union ...